• FirefoxInstall the new Firefox »
  •  Dow Down 0.58% Nasdaq Down 0.26%

    More On AMGN.BA

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Amgen Inc. (AMGN.BA)

    -Buenos Aires
    373.50 0.00(0.00%) Feb 23
    Add to Portfolio
    Prev Close:373.50
    Open:373.50
    Bid:373.50
    Ask:373.50
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:373.50 - 373.50
    52wk Range:193.55 - 373.50
    Volume:810
    Avg Vol (3m):N/A
    Market Cap:283.43B
    P/E (ttm):55.75
    EPS (ttm):6.70
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in ARS.

    Headlines

    • No Headlines available for AMGN.BA at this time.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):14.13
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Amgen Inc., a biotechnology company, discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses for the treatment of illness in the areas of oncology, hematology, inflammation, bone health, nephrology, cardiovascular,... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback